Cover Image
Market Research Report

Global Body Composition Analyzers Market - Trends and Forecast to 2024

Published by Data Bridge Market Research Private Limited Product code 536507
Published Content info 214 Pages; 87 Tables; 62 Figures
Delivery time: 1-2 business days
Price
Back to Top
Global Body Composition Analyzers Market - Trends and Forecast to 2024
Published: July 1, 2017 Content info: 214 Pages; 87 Tables; 62 Figures
Description

Synopsis:

Global Body Composition Analyzers Market is expected to reach USD 1,790.50 million by 2024, at a CAGR of 7.6% during the forecast period of 2017 to 2024. The report contains 215 pages of exclusive premium insights with 87 tables and 65 figures.

Global Body Composition Analyzers Market is segmented based on product type, end-users and geography.

On the basis of route of administration the market is segmented into Bio impedance Analyzers (BIA), Dual-Energy X-Ray Absorptiometry (DEXA), Skinfold Calipers, Air Displacement Plethysmography (ADP), and others (Hydrostatic Weighing (HwD), Ultrasound Body Composition

On the basis of end users the market is segmented into Health Clubs, Hospitals and Clinics, Corporate Settings, and others (Medical Research, Universities).

The global body composition analyzers market is segmented into 5 regions such as North America, Europe, Asia-Pacific, South America and Middle East and Africa.

Major Players Operating in this market:

Tanita (Japan), InBody CO., LTD. (South Korea), along with others are, Omron Healthcare, Inc. (Japan), Selvashealthcare (Korea), Bodystat (U.K.), Hologic, Inc. (U.S.), GE Healthcare (U.K.), COSMED (Italy), Beurer GmbH (Germany), seca (Germany), RJL SYSTEMS (U.S.A), Maltron International Ltd. (U.K.), LaicaSpA (Italy) among others.

Regions Covered In The Scope Of The Report:

Global (North America (U.S., Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain, Russia, Belgium, Netherlands, Switzerland, Turkey, Rest of Europe), Asia-Pacific (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC), South America (Brazil, Rest of South America), Middle East and Africa( South Africa, Rest of MEA)).

Table of Contents

Table of Contents

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. OVERVIEW OF GLOBAL BODY COMPOSITION ANALYZERS MARKET
  • 1.4. CURRENCY AND PRICING
  • 1.5. LIMITATION
  • 1.6. MARKETS COVERED

2. MARKET SEGMENTATION

  • 2.1. MARKETS COVERED
  • 2.2. GEOGRAPHIC SCOPE
  • 2.3. YEARS COVERED FOR THE STUDY
  • 2.4. CURRENCY AND PRICING

3. RESEARCH METHODOLOGY

  • 3.1. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 3.2. SECONDARY SOURCES
  • 3.3. ASSUMPTIONS

4. MARKET OVERVIEW

  • 4.1. DRIVERS
    • 4.1.1. AGING POPULATION GLOBALLY
    • 4.1.2. RISING OBESITY GLOBALLY
    • 4.1.3. GOVERNMENT INITIATIVES
    • 4.1.4. KEY PLAYERS ARE TAKING STRATEGIC DECISIONS TO GAIN MARKET SHARE
    • 4.1.5. INCREASING DISEASES DUE TO CHANGING LIFESTYLE
  • 4.2. RESTRAINTS
    • 4.2.1. REGULATORY FRAMEWORK
    • 4.2.2. HIGH COST OF EQUIPMENT
  • 4.3. OPPORTUNITIES
    • 4.3.1. RISING FITNESS INDUSTRY
    • 4.3.2. GROWING NUMBER OF WEIGHT LOSS CLINICS
  • 4.4. CHALLENGES
    • 4.4.1. REQUIREMENT OF TRAINED STAFF
    • 4.4.2. INCONSISTENT RESULTS

5. PREMIUM INSIGHTS

6. EXECUTIVE SUMMARY

7. GLOBAL BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT TYPE

  • 7.1. OVERVIEW
  • 7.2. BIO IMPEDANCE ANALYZERS (BIA)
  • 7.3. SKINFOLD CALIPER
  • 7.4. DUAL ENERGY X-RAY ABSORPTIOMETRY (DEXA)
  • 7.5. AIR DISPLACEMENT PLETHYSMOGRAPHY (ADP)
  • 7.6. OTHERS

8. GLOBAL BODY COMPOSITION ANALYZERS MARKET, BY END USER

  • 8.1. OVERVIEW
  • 8.2. HOSPITALS AND CLINICS
  • 8.3. CORPORATE SETTINGS
  • 8.4. HEALTH CLUBS
  • 8.5. OTHER END USERS

9. GLOBAL BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
    • 9.2.3. MEXICO
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. FRANCE
    • 9.3.3. U.K.
    • 9.3.4. ITALY
    • 9.3.5. SPAIN
    • 9.3.6. RUSSIA
    • 9.3.7. TURKEY
    • 9.3.8. BELGIUM
    • 9.3.9. NETHERLANDS
    • 9.3.10. SWITZERLAND
    • 9.3.11. REST OF EUROPE
  • 9.4. APAC
    • 9.4.1. JAPAN
    • 9.4.2. CHINA
    • 9.4.3. SOUTH KOREA
    • 9.4.4. INDIA
    • 9.4.5. AUSTRALIA
    • 9.4.6. SINGAPORE
    • 9.4.7. THAILAND
    • 9.4.8. MALAYSIA
    • 9.4.9. INDONESIA
    • 9.4.10. PHILIPPINES
    • 9.4.11. REST OF APAC
  • 9.5. SOUTH AMERICA
    • 9.5.1. BRAZIL
    • 9.5.2. REST OF SOUTH AMERICA
  • 9.6. MEA
    • 9.6.1. SOUTH AFRICA
    • 9.6.2. REST OF MEA

10. GLOBAL BODY COMPOSITION ANALYZERS MARKET,

COMPANY LANDSCAPE 186

  • 10.1. COMPANY SHARE ANALYSIS: GLOBAL
  • 10.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 10.3. COMPANY SHARE ANALYSIS: EUROPE
  • 10.4. COMPANY SHARE ANALYSIS: APAC

11. COMPANY PROFILES

  • 11.1. COSMED
    • 11.1.1. COMPANY OVERVIEW
    • 11.1.2. REVENUE ANALYSIS
    • 11.1.3. PRODUCT PORTFOLIO
    • 11.1.4. RECENT DEVELOPMENTS
  • 11.2. GE HEALTHCARE
    • 11.2.1. COMPANY OVERVIEW
    • 11.2.2. REVENUE ANALYSIS
    • 11.2.3. PRODUCT PORTFOLIO
    • 11.2.4. RECENT DEVELOPMENTS
  • 11.3. OMRON HEALTHCARE INC.
    • 11.3.1. COMPANY OVERVIEW
    • 11.3.2. REVENUE ANALYSIS
    • 11.3.3. PRODUCT PORTFOLIO
    • 11.3.4. RECENT DEVELOPMENTS
  • 11.4. SECA
    • 11.4.1. COMPANY OVERVIEW
    • 11.4.2. REVENUE ANALYSIS
    • 11.4.3. PRODUCT PORTFOLIO
    • 11.4.4. RECENT DEVELOPMENTS
  • 11.5. TANITA
    • 11.5.1. COMPANY OVERVIEW
    • 11.5.2. REVENUE ANALYSIS
    • 11.5.3. PRODUCT PORTFOLIO
    • 11.5.4. RECENT DEVELOPMENTS
  • 11.6. HOLOGIC INC.
    • 11.6.1. COMPANY OVERVIEW
    • 11.6.2. REVENUE ANALYSIS
    • 11.6.3. PRODUCT PORTFOLIO
    • 11.6.4. RECENT DEVELOPMENTS
  • 11.7. INBODY CO LTD.
    • 11.7.1. COMPANY OVERVIEW
    • 11.7.2. REVENUE ANALYSIS
    • 11.7.3. PRODUCT PORTFOLIO
    • 11.7.4. RECENT DEVELOPMENTS
  • 11.8. SELVAS HEALTHCARE
    • 11.8.1. COMPANY OVERVIEW
    • 11.8.2. REVENUE ANALYSIS
    • 11.8.3. PRODUCT PORTFOLIO
    • 11.8.4. RECENT DEVELOPMENTS
  • 11.9. BEURER GMBH
    • 11.9.1. COMPANY OVERVIEW
    • 11.9.2. REVENUE ANALYSIS
    • 11.9.3. PRODUCT PORTFOLIO
    • 11.9.4. RECENT DEVELOPMENTS
  • 11.10. BODYSTAT
    • 11.10.1. COMPANY OVERVIEW
    • 11.10.2. REVENUE ANALYSIS
    • 11.10.3. PRODUCT PORTFOLIO
    • 11.10.4. RECENT DEVELOPMENTS
  • 11.11. RJL SYSTEMS, INC.
    • 11.11.1. COMPANY OVERVIEW
    • 11.11.2. REVENUE ANALYSIS
    • 11.11.3. PRODUCT PORTFOLIO
    • 11.11.4. RECENT DEVELOPMENTS
  • 11.12. LAICA SPA
    • 11.12.1. COMPANY OVERVIEW
    • 11.12.2. REVENUE ANALYSIS
    • 11.12.3. PRODUCT PORTFOLIO
    • 11.12.4. RECENT DEVELOPMENTS
  • 11.13. MALTRON INTERNATIONAL LTD.
    • 11.13.1. COMPANY OVERVIEW
    • 11.13.2. REVENUE ANALYSIS
    • 11.13.3. PRODUCT PORTFOLIO
    • 11.13.4. RECENT DEVELOPMENTS

12. RELATED REPORTS

Back to Top